Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Multicentric Cohort Study of Severe and Very Severe COPD Patients in Brazil.

NCT06780046 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06780046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06780046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Multicentric Cohort Study of Severe and Very Severe COPD Patients in Brazil.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
January 31, 2025
Completion date
September 30, 2027
Enrollment
693 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

copd (chronic obstructive pulmonary disease)